![Anders Martin-Löf](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anders Martin-Löf
Directeur Financier/CFO chez
BIOARCTIC AB
Fortune : 101 667 $ au 30/06/2026
Profil
Anders Martin-Löf is currently serving as an Independent Director at Cantargia AB, a Director at Oncopeptides Incentive AB, a Director at Lisa Martin-Löf Konsultbyrå AB, a Director at Affibody Medical AB, and will be the Chief Financial Officer & Secretary at BioArctic AB starting in 2023.
Previously, he held the position of Chief Financial Officer & Deputy CEO at Oncopeptides AB from 2018 to 2021.
He also served as a Director of Investor Relations at Biovitrum AB, a Director at Sciencecap Stockholm AB, the CFO, Investor Relations & Press Contact at RaySearch Laboratories AB from 2014 to 2015, the Chief Financial Officer at Extenda AB, the Head of Investor Relations at Swedish Orphan Biovitrum AB from 2006 to 2007, the Chief Financial Officer at Wilson Therapeutics AB from 2015 to 2018, and the Chief Financial Officer at A3P Biomedical AB (publ).
Mr. Martin-Löf obtained his undergraduate degree from the University of Stockholm, his graduate degree from the Royal Institute of Technology, and another graduate degree from ENSIMAG.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/04/2025 | 2 500 ( 0 % ) | 85 037 $ | 30/06/2026 | |
CANTARGIA AB 0,03 % | 31/12/2024 | 75 000 ( 0,03 % ) | 16 631 $ | 30/06/2026 |
Postes actifs de Anders Martin-Löf
| Sociétés | Poste | Début |
|---|---|---|
| CANTARGIA AB | Directeur/Membre du Conseil | 01/01/2018 |
| BIOARCTIC AB | Directeur Financier/CFO | 01/06/2023 |
Lisa Martin-Löf Konsultbyrå AB | Directeur/Membre du Conseil | - |
Oncopeptides Incentive AB | Directeur/Membre du Conseil | - |
Affibody Medical AB
 Affibody Medical AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceuticals services | Directeur/Membre du Conseil | 01/12/2021 |
Anciens postes connus de Anders Martin-Löf
| Sociétés | Poste | Fin |
|---|---|---|
| ONCOPEPTIDES AB | Directeur Financier/CFO | 08/11/2021 |
| WILSON THERAPEUTICS AB | Directeur Financier/CFO | 01/08/2018 |
| RAYSEARCH LABORATORIES AB | Directeur Financier/CFO | 02/07/2015 |
| SWEDISH ORPHAN BIOVITRUM AB | Investor Relations Contact | 01/07/2007 |
| ░░░ ░░░░░░░░░░ ░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | - |
Formation de Anders Martin-Löf
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
46
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
RaySearch Laboratories AB
 RaySearch Laboratories AB Packaged SoftwareTechnology Services Supplies computer software that improves the efficacy of radiation therapy for cancer | Technology Services |
Affibody Medical AB
Affibody Medical AB Pharmaceuticals: MajorHealth Technology Provides biopharmaceuticals services | Health Technology |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Commercial Services |
University of Stockholm
 University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopeptides AB
 Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
Royal Institute of Technology
 Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ENSIMAG
 ENSIMAG Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioArctic AB
 BioArctic AB Pharmaceuticals: MajorHealth Technology Develops drugs for patients with disorders of the central nervous systems | Health Technology |
Extenda AB
 Extenda AB Information Technology ServicesTechnology Services Provides information technology solutions | Technology Services |
Cantargia AB
 Cantargia AB Pharmaceuticals: MajorHealth Technology Creates and develops antibody therapeutics for the treatment of leukemia | Health Technology |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Wilson Therapeutics AB
 Wilson Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company focusing in treatment of Wilson disease | Health Technology |
Oncopeptides Incentive AB | |
Sciencecap Stockholm AB | |
Lisa Martin-Löf Konsultbyrå AB | |
A3P Biomedical AB (publ)
 A3P Biomedical AB (publ) Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Choisissez Zonebourse 
